Cancer Care Management During the COVID-19 Pandemic.

SARS-CoV-2 cancer coronavirus health care pandemic

Journal

Risk management and healthcare policy
ISSN: 1179-1594
Titre abrégé: Risk Manag Healthc Policy
Pays: England
ID NLM: 101566264

Informations de publication

Date de publication:
2020
Historique:
received: 05 05 2020
accepted: 02 09 2020
entrez: 16 10 2020
pubmed: 17 10 2020
medline: 17 10 2020
Statut: epublish

Résumé

New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing around the world. Currently, health care services are mainly focused on responding to and controlling the unique challenges of the coronavirus disease 2019 (COVID-19) pandemic. These changes, along with the higher susceptibility of patients with cancer to infections, have profound effects on other critical aspects of care and pose a serious challenge for the treatment of such patients. During the COVID-19 pandemic, it is important to provide strategies for managing the treatment of patients with cancer to limit COVID-19-associated risks at this difficult time. The present study set out to summarize the latest research on epidemiology, pathogenesis, and clinical features of COVID-19. We also address some of the current challenges associated with the management of patients with cancer during the COVID-19 pandemic and provide practical guidance to clinically deal with these challenges.

Identifiants

pubmed: 33061705
doi: 10.2147/RMHP.S261357
pii: 261357
pmc: PMC7520144
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1711-1721

Informations de copyright

© 2020 Jafari et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Microbiol Mol Biol Rev. 2005 Dec;69(4):635-64
pubmed: 16339739
Cancer Cell. 2013 Aug 12;24(2):229-41
pubmed: 23871637
mBio. 2018 Mar 6;9(2):
pubmed: 29511076
Updates Surg. 2020 Jun;72(2):291-295
pubmed: 32495280
J Clin Invest. 2020 Apr 1;130(4):1545-1548
pubmed: 32167489
P T. 2011 Nov;36(11):740-57
pubmed: 22346307
Curr Oncol. 2006 Aug;13(4):119-20
pubmed: 17576451
Arch Acad Emerg Med. 2020 Mar 21;8(1):e29
pubmed: 32232214
ESMO Open. 2020 Mar;5(2):
pubmed: 32229501
Biol Blood Marrow Transplant. 2020 Jul;26(7):1239-1246
pubmed: 32298807
Oncologist. 2020 Jun;25(6):e936-e945
pubmed: 32243668
Lancet. 2018 Mar 10;391(10124):933
pubmed: 29536852
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Viruses. 2019 Oct 18;11(10):
pubmed: 31635238
Lancet Respir Med. 2020 Jun;8(6):542-544
pubmed: 32278368
Indian J Pharmacol. 2020 Jan-Feb;52(1):56-65
pubmed: 32201449
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Science. 2013 Aug 16;341(6147):702
pubmed: 23950504
Int J Antimicrob Agents. 2020 May;55(5):105954
pubmed: 32234467
J Cell Physiol. 2020 Jan;235(1):31-64
pubmed: 31215038
Mil Med Res. 2020 Mar 13;7(1):11
pubmed: 32169119
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Clin Pharmacol Ther. 2019 Aug;106(2):415-421
pubmed: 30739322
J Cell Physiol. 2019 May;234(5):5399-5412
pubmed: 30565667
Health Psychol. 2020 May;39(5):355-357
pubmed: 32202824
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
BJU Int. 2020 Jun;125(6):E7-E14
pubmed: 32249538
Lancet. 2020 Jun 20;395(10241):1907-1918
pubmed: 32473681
Oncologist. 2018 Aug;23(8):879-886
pubmed: 29802219
J Am Coll Cardiol. 2019 Dec 24;74(25):3153-3163
pubmed: 31856973
Biosci Trends. 2020 Mar 16;14(1):69-71
pubmed: 31996494
Asian Pac J Cancer Prev. 2020 Mar 01;21(3):569-573
pubmed: 32212779
ESMO Open. 2020 Apr;5(2):
pubmed: 32245904
Curr Oncol Rep. 2020 May 28;22(6):60
pubmed: 32462289
Respirology. 2018 Feb;23(2):130-137
pubmed: 29052924
J Med Virol. 2020 May;92(5):491-494
pubmed: 32056249
Breast Cancer Res Treat. 2020 Jun;181(3):487-497
pubmed: 32333293
Mol Cancer Res. 2020 Aug;18(8):1113-1128
pubmed: 32430354
Nat Rev Clin Oncol. 2020 May;17(5):268-270
pubmed: 32242095
J Korean Med Sci. 2020 Feb 17;35(6):e79
pubmed: 32056407
Saf Health Work. 2020 Jun;11(2):241-243
pubmed: 32292622
Indian J Surg Oncol. 2020 May 6;:1-8
pubmed: 32382219
Virol J. 2005 Aug 22;2:69
pubmed: 16115318
Viruses. 2020 Apr 10;12(4):
pubmed: 32290077
Ann Intensive Care. 2018 Oct 29;8(1):102
pubmed: 30374729
J Med Virol. 2020 Jun;92(6):548-551
pubmed: 32096567
Monaldi Arch Chest Dis. 2020 Mar 30;90(1):
pubmed: 32231348
Exp Physiol. 2008 May;93(5):543-8
pubmed: 18448662
Biochem Biophys Res Commun. 2005 Jan 28;326(4):905-8
pubmed: 15607755
Updates Surg. 2020 Sep;72(3):867-869
pubmed: 32537687
J Med Virol. 2020 May;92(5):518-521
pubmed: 32022275
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Viruses. 2020 Mar 27;12(4):
pubmed: 32230900
JACC CardioOncol. 2020 Jun;2(2):350-355
pubmed: 32292919
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Cardiol Clin. 2019 Nov;37(4):385-397
pubmed: 31587780
J Autoimmun. 2020 Jul;111:102452
pubmed: 32291137
Breast J. 2017 Jul;23(4):444-451
pubmed: 28117507
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Lancet Oncol. 2020 Apr;21(4):e180
pubmed: 32142622
J Med Virol. 2020 Apr;92(4):441-447
pubmed: 31994742
Nat Rev Clin Oncol. 2020 Jun;17(6):329-331
pubmed: 32296166
Zool Res. 2020 May 18;41(3):247-257
pubmed: 32351056
Cancer Invest. 2020 May;38(5):310-328
pubmed: 32274949
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Int J Antimicrob Agents. 2020 Jun;55(6):105948
pubmed: 32201353
Trends Cardiovasc Med. 2020 Aug;30(6):315-325
pubmed: 32474135
J Med Virol. 2020 Apr;92(4):424-432
pubmed: 31981224
Eur J Pharmacol. 2020 Jul 5;878:173107
pubmed: 32278856
Cureus. 2020 Mar 20;12(3):e7343
pubmed: 32226695

Auteurs

Ameneh Jafari (A)

Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mostafa Rezaei-Tavirani (M)

Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Samira Karami (S)

Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohsen Yazdani (M)

Department of Bioinformatics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Hakimeh Zali (H)

Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Zahra Jafari (Z)

9Dey Manzariye Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Classifications MeSH